ML Provides Personalized Hypertension Treatment Recommendations https://ift.tt/cEAPUoR via HealthITAnalytics https://ift.tt/K6br8k9 June 9, 2023 at 11:07PM
STAT+: FDA panel unanimously endorses Eisai’s Alzheimer’s drug
STAT+: FDA panel unanimously endorses Eisai’s Alzheimer’s drug https://ift.tt/dXaSUHo Adam Feuerstein and Damian Garde via STAT https://ift.tt/VuNJoAF June 9, 2023 at 11:00PM
STAT+: Drug companies and pharmacies reach $17.3 billion settlement over opioid crisis
STAT+: Drug companies and pharmacies reach $17.3 billion settlement over opioid crisis https://ift.tt/WY6dgo9 Ed Silverman via STAT https://ift.tt/VuNJoAF June 9, 2023 at 10:38PM
FDA’s letter to medical device maker iRhythm is a warning for the industry
FDA’s letter to medical device maker iRhythm is a warning for the industry https://ift.tt/0CGL4Nd Lizzy Lawrence via STAT https://ift.tt/VuNJoAF June 9, 2023 at 10:01PM
Eisai, Biogen’s Alzheimer’s disease drug Leqembi passes muster at FDA adcomm
Eisai, Biogen’s Alzheimer’s disease drug Leqembi passes muster at FDA adcomm https://ift.tt/zBNEyw3 esagonowsky via FiercePharma https://ift.tt/MpDrFKZ June 9, 2023 at 10:00PM
FDA adcomm votes unanimously in favor of full approval for Eisai’s new Alzheimer’s drug
FDA adcomm votes unanimously in favor of full approval for Eisai’s new Alzheimer’s drug https://ift.tt/xJ4pg27 Zachary Brennan via Endpoints https://endpts.com June 9, 2023 at 09:57PM